These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 7268446)

  • 1. Carcinogen-DNA adducts in mutagenesis assays.
    Grunberger D; Santella RM; Weinstein IB
    Science; 1981 Sep; 213(4514):1411-2. PubMed ID: 7268446
    [No Abstract]   [Full Text] [Related]  

  • 2. Mutagenesis assays with bacteria.
    Davis A; Devoret R; Green M; Hofnung M; Kawachi T; Matsushima T; McCann J; Mohn GR; Norpoth K; Radman M; Rosenkranz HS; Venitt S
    IARC Monogr Eval Carcinog Risk Chem Hum Suppl; 1980; (2 Suppl):85-106. PubMed ID: 6450174
    [No Abstract]   [Full Text] [Related]  

  • 3. Contribution of DNA methylation and benzylation to N-nitroso-N-benzyl-methylamine-induced mutagenesis in bacteria: effects of rat liver cytochrome P450 isozymes and glutathione transferases.
    Lin DX; Malaveille C; Park SS; Gelboin HV; Bartsch H
    Carcinogenesis; 1990 Sep; 11(9):1653-8. PubMed ID: 2119260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 5. Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals.
    Mortelmans K; Haworth S; Lawlor T; Speck W; Tainer B; Zeiger E
    Environ Mutagen; 1986; 8 Suppl 7():1-119. PubMed ID: 3516675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
    Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
    Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
    [No Abstract]   [Full Text] [Related]  

  • 7. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
    Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
    Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential in vivo mutagenicity of the carcinogen/non-carcinogen pair 2,4- and 2,6-diaminotoluene.
    Hayward JJ; Shane BS; Tindall KR; Cunningham ML
    Carcinogenesis; 1995 Oct; 16(10):2429-33. PubMed ID: 7586147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of the correlation of bacterial mutagenicity with carcinogenicity of benzo(a)pyrene and four of its major metabolites by activation with intact liver cells instead of cell homogenate.
    Glatt HR; Billings R; Platt KL; Oesch F
    Cancer Res; 1981 Jan; 41(1):270-7. PubMed ID: 7448766
    [No Abstract]   [Full Text] [Related]  

  • 10. Carcinogenicity and mutagenicity of N-nitroso compounds.
    Lijinsky W
    Mol Toxicol; 1987; 1(1):107-19. PubMed ID: 3329700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bovine bladder and liver cell and homogenate-mediated mutagenesis of Salmonella typhimurium with aromatic amines.
    Hix C; Oglesby L; MacNair P; Sieg M; Langenbach R
    Carcinogenesis; 1983 Nov; 4(11):1401-7. PubMed ID: 6357520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic activation of chemicals to mutagenic carcinogens by human hepatoma microsomal extracts in Chinese hamster ovary cells (in vitro).
    Darroudi F; Natarajan AT
    Mutagenesis; 1993 Jan; 8(1):11-5. PubMed ID: 8383795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagens, carcinogens, and computers.
    Rosenkranz HS; Klopman G
    Prog Clin Biol Res; 1986; 209A():71-104. PubMed ID: 3529111
    [No Abstract]   [Full Text] [Related]  

  • 14. N-Nitrosodiphenylamine.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 Apr; 27():213-25. PubMed ID: 7049904
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of metabolic activation of 7,12-dimethylbenz(a)anthracene in vitro by aroclor 1254-induced rat liver S-9 fraction.
    Bigger CA; Tomaszewski JE; Andrews AW; Dipple A
    Cancer Res; 1980 Mar; 40(3):655-61. PubMed ID: 6781743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The in vitro metabolic activation of the 11-trifluoromethyl analogue of the potent carcinogen 15,16-dihydro-11-methyl-cyclopenta[a]-phenanthren-17-one to mutagens.
    Boyd GW; Zepik HH; King LM; Ioannides C; Coombs MM
    Carcinogenesis; 1993 Aug; 14(8):1697-9. PubMed ID: 8353854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aromatic hydrocarbons on the metabolism of 2-aminoanthracene to mutagenic products in the Ames assay.
    Kawalek JC; Andrews AW
    Carcinogenesis; 1981; 2(12):1367-9. PubMed ID: 7034989
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of dietary protein deficiency on the ability of isolated hepatic microsomes to alter the mutagenicity of a primary and a secondary carcinogen.
    Czygan P; Greim H; Garro A; Schaffner F; Popper H
    Cancer Res; 1974 Jan; 34(1):119-23. PubMed ID: 4588542
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro screening of carcinogens using DNA of the His- mutant of Salmonella typhimurium.
    Beljanski M; Le Goff L; Beljanski M
    Exp Cell Biol; 1982; 50(5):271-80. PubMed ID: 6754496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2,4,5- and 2,4,6-Trimethylaniline and their hydrochlorides.
    IARC Monogr Eval Carcinog Risk Chem Hum; 1982 Apr; 27():177-88. PubMed ID: 7049902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.